Biopsy Devices Market
March 4, 2025

Biopsy Devices Market 2025: Analysis, Top Companies, Size, Share and Opportunity To 2033

Market Overview:

The global biopsy devices market, valued at USD 2.8 billion in 2024, is expected to grow to USD 4.6 billion by 2033, expanding at a CAGR of 5.47%. This growth is primarily driven by the rising prevalence of cancer, the increasing adoption of personalized medicine, and the demand for minimally invasive procedures. These factors are enhancing patient comfort and accelerating recovery times, further propelling the market.

STUDY ASSUMPTION YEARS:

  • BASE YEAR: 2024
  • HISTORICAL YEAR: 2019-2024
  • FORECAST YEAR: 2025-2033

BIOPSY DEVICES MARKET KEY TAKEAWAYS:

  • The biopsy devices market is forecasted to reach USD 4.6 billion by 2033, with a CAGR of 5.47%.
  • Rising cancer rates and early diagnostic needs are major market drivers.
  • Technological innovations, such as image-guided biopsy techniques, are enhancing the precision of procedures.
  • North America is the dominant market due to strong healthcare infrastructure.
  • The increasing adoption of minimally invasive procedures is improving patient outcomes.
  • Asia-Pacific is emerging as a key growth region with rising healthcare awareness.

MARKET GROWTH FACTORS:

Technological Developments: The major drivers for the biopsy devices market are significant technological advancements. The surge associated with this market resulted from the action of slowly evolving traditional advances, which included vacuum-assisted biopsy unit(ies) and such image-guided procedures as ultrasound, MRI, and the stereotactic-guided one. Development in biopsy guiding technology has seen the biopsy results put to work more accurately in a speedy manner. Because the tools used tend not only to improve accuracy of diagnosis and consign less discomfort to the patient, they hasten the process and disengage ceremoniously from the invasion into the patient’s body. Computer-driven assisting systems like AI and machine learning (up-and-coming hardwoods onset) are seeing help; they are escalating in their services and they aim to articulate biopsies in a somewhat efficient manner compatible with clinical sense. These transitions are deemed likely to leave all chapters closed with regard to the overall growth of the biopsy devices market. There will be prospects piled at the doorstep for a future with demand for diagnostic tool-intensive solutions.

Rising Cancer: The increasing global incidence of cancer is increasing pressure worldwide for early diagnosis. Noteworthy global cancer deaths translate into providing the healthcare industry with a never-ending search for early detection tools. Biopsy devices are core for identifying various stages of cancers for more focused individual therapies. An increasing number of cancer patients coupled with increasing awareness of screening programs propels the demand for biopsy devices. With greater attention channeled towards earlier diagnosis, the biopsy devices market will continue to grow. Yet another straw from the same bundle of straws allocated to the pile on the ground for early diagnostic needs.

Minimally Invasive Procedures:There is a big shift towards minimally invasive biopsy techniques as patients prefer less invasive procedures. This shift allows such benefits as faster recovery times, fewer complications during the procedure, and lower costs of healthcare. The burgeoning preference for this therapy drives the uptake of image-guided biopsies, providing higher accuracy and less discomfort. This is expected to be the factor, which propels the growth of the biopsy devices market as healthcare providers chase after the call of the patients for safe and effective procedures.

Request Sample For PDF Report: https://www.imarcgroup.com/biopsy-devices-market/requestsample

Market Segmentation:

Breakup by Procedure Type: 

  • Surgical Biopsy
  • Needle Biopsy

Breakup by Product:

  • Biopsy Guidance Systems
  • Needle Based Biopsy Guns
  • Biopsy Needles
  • Biopsy Forceps
  • Others

Breakup by Application:

  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Prostate Biopsy
  • Others

Breakup by Guidance Technique:

  • Ultrasound Guided Biopsy
  • Stereotactic Guided Biopsy
  • MRI Guided Biopsy
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

REGIONAL INSIGHTS:

North America leads the biopsy devices market, driven by its robust healthcare infrastructure, high levels of healthcare spending, and presence of leading device manufacturers. The region is seeing significant growth due to increasing cancer diagnoses and advanced diagnostic technologies.

RECENT DEVELOPMENTS & NEWS:

Recent advancements in biopsy devices have seen an increase in the use of liquid biopsies, offering non-invasive alternatives for cancer detection. There is also an ongoing trend towards integrating artificial intelligence in diagnostic processes, improving accuracy and decision-making for clinicians. The adoption of minimally invasive techniques continues to rise, contributing to faster recovery and lower infection risks. These innovations are shaping the future of biopsy procedures.

Key Players:

  • Argon Medical Devices
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • CONMED Corporation
  • Cook Group Incorporated
  • Hologic Inc.
  • INRAD Inc.
  • Medtronic plc

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.